Secor Capital Advisors’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-20,871
| Closed | -$259K | – | 281 |
|
|
2019
Q1 | $259K | Sell |
20,871
-146,164
| -88% | -$1.81M | 0.05% | 294 |
|
|
2018
Q4 | $1.03M | Buy |
+167,035
| New | +$1.03M | 0.13% | 181 |
|
|
2018
Q1 | – | Sell |
-73,854
| Closed | -$927K | – | 616 |
|
|
2017
Q4 | $927K | Buy |
73,854
+3,978
| +6% | +$49.9K | 0.04% | 247 |
|
|
2017
Q3 | $1.33M | Buy |
69,876
+30,470
| +77% | +$580K | 0.13% | 197 |
|
|
2017
Q2 | $595K | Buy |
+39,406
| New | +$595K | 0.05% | 277 |
|
|
2017
Q1 | – | Sell |
-27,195
| Closed | -$329K | – | 549 |
|
|
2016
Q4 | $329K | Sell |
27,195
-159,753
| -85% | -$1.93M | 0.04% | 329 |
|
|
2016
Q3 | $1.84M | Buy |
186,948
+126,392
| +209% | +$1.24M | 0.2% | 134 |
|
|
2016
Q2 | $620K | Buy |
+60,556
| New | +$620K | 0.08% | 286 |
|